Mesoblast Share Price Up on FDA ‘Fast Track’ Designation (ASX:MSB)
At time of writing the Mesoblast Ltd [ASX:MSB] share price is up 7.26%. Soaring on the back of some exciting news. Their remestemcel-L treatment has secured ‘fast track’ status from the US Food & Drug Administration (FDA)…





